Triphala
Best-in-class: Triphala
A three-fruit Ayurvedic combination used as a gentle bowel regulator — traditionally positioned as a tonic rather than a laxative.
Triphala quick facts
| Suggested dose | 500 mg – 1 g at night. |
| How often | Daily |
| Who it's for | Sluggish but not obstructed bowels; a gentler option than stimulant laxatives. |
The better default for chronic constipation than a stimulant laxative, precisely because it does not cause the colonic dependence. Trial evidence supports it for constipation and there is emerging work on its prebiotic effect. Takes days rather than hours. Traditional Ayurvedic use is extensive, and the quality of commercial products varies enormously.
How Triphala actually works
Amalaki, bibhitaki and haritaki combined. It acts as a bowel regulator through a combination of mild osmotic effect, tannin content and prokinetic action, rather than as a stimulant laxative — which is why it does not produce the dependence senna does. It also has genuine antioxidant and antimicrobial activity.
Where to get Triphala
Find Triphala on iHerb →The evidence for Triphala
Graded by what exists behind each claim.
✅ Clinically validated
- Small trials suggest improved bowel regularity and some antioxidant effects. The evidence base is small and largely regional.
📊 Correlative data
- One of the most widely used formulations in Ayurveda, with centuries of continuous use.
🧪 Theoretical / extrapolated benefits
- Tannin and polyphenol content is proposed to support the mucosal barrier and act as a mild prebiotic.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Triphala actually does
Three dried fruits, classically in equal parts by weight: Phyllanthus emblica (amalaki), Terminalia bellirica (bibhitaki) and Terminalia chebula (haritaki) Peterson 2017. The chemistry they share is hydrolyzable tannin — chebulagic acid, chebulinic acid, corilagin and a family of ellagitannins — sitting on top of free gallic acid and ellagic acid, with the amalaki fruit contributing ascorbate and emblicanins.
The first thing to understand is that almost none of it gets in. Ellagitannins are large, polar and heavily hydroxylated, and their oral bioavailability as intact molecules is negligible. In the gut they are hydrolyzed to ellagic acid, and ellagic acid is then converted by specific colonic bacteria — Gordonibacter and Ellagibacter among them — through a sequence of dehydroxylations into urolithins. Urolithin A is the metabolite that actually reaches your bloodstream, and it is the only compound here with meaningful oral bioavailability. That matters enormously, because the capacity to make it is not universal: people fall into distinct urolithin metabotypes, and a substantial fraction of any population produces little or none. Any systemic claim for this formula therefore runs through a piece of microbial machinery you either have or do not, and no product has ever mentioned it.
The local action does not need absorption at all. Tannins are astringent by definition: they cross-link and precipitate proteins, including mucosal and bacterial surface proteins, and by that same binding they inhibit digestive enzymes such as amylase. That is a physical chemistry effect happening at the epithelial surface, it needs no transporter, and it is the plausible basis for the traditional use in the gut. It is also why the same molecules chelate iron and other metals in the lumen — the same binding, pointed at a different partner.
The bowel effect, described honestly. This formula is positioned as a regulator rather than a stimulant laxative, and the review literature on functional gastrointestinal disorders treats its action as multi-component — motility, secretion and the mucosal surface together — rather than as one purgative constituent Tarasiuk 2018. Nobody has isolated which fraction produces the loose stool that tells you the dose is too high, and until somebody does, “gentle” is a description of the experience and not an explanation.
Cell, rodent, human — and where it stops
In cells and rodents. The antioxidant, antimicrobial and gastroprotective work sits almost entirely in vitro and in rodent models, and the reviews that collect it say so plainly Peterson 2017 Tarasiuk 2018. Doses in rodent studies are typically expressed per kilogram and scale to grams per day in an adult human, which is above what the shelf recommends.
The one randomized human trial with a mechanistic read-out, and its actual size. Thirty-one healthy adults were randomized to triphala (n = 9), manjistha (n = 9) or placebo (n = 11) and took 2,000 mg/day by mouth for four weeks, with stool sequencing before and after. An average of 336 phylotypes were detected per sample across the 28 days. The result was a TREND toward a lower Firmicutes-to-Bacteroidetes ratio and a higher relative abundance of Akkermansia muciniphila Peterson 2020. A trend in nine people is a reason to run a bigger study, and it is the strongest randomized evidence this formula has for anything.
The obstacle is the dose, and it points the opposite way from usual. On this site the card says 500 mg to 1 g at night. The only randomized human data used 2,000 mg/day Peterson 2020 — two to four times the label. The usual complaint about supplements is that the trial dose was far above the bottle; here that is also true, and it is true of the only randomized trial there is.
The second obstacle is that “triphala” is not a defined substance. Equal parts by weight is the classical formula Peterson 2017, but tannin content varies with harvest, with fruit ripeness and with whether the material was extracted or simply powdered. No trial has published the chebulagic or chebulinic acid content of what it gave, so even a perfectly run study cannot be reproduced from the paper. Two bottles both correctly labeled “triphala” can differ severalfold in the molecules that do the work.
Triphala — which form, and does it matter
Churna against extract, and the ratio nobody prints. The traditional preparation is a churna — raw dried fruit milled to powder, taken by the gram. Capsules usually contain either that powder or a concentrated extract at some undisclosed ratio, so 500 mg on a label describes two different doses. A 500 mg capsule of a 10:1 extract is not a smaller dose of the same thing as 500 mg of churna; it is a different preparation with different tannin content and a different bowel effect at the same milligram number.
Standardizing to gallic acid is close to meaningless. Gallic acid is the common hydrolysis product of essentially every hydrolyzable tannin in all three fruits and of a hundred other plants. A “standardized to 40% gallic acid” claim tells you how much the material has already been broken down, not how much of the intact chebulagic and chebulinic acid — the molecules the chemistry papers name Peterson 2017 — survived into the capsule.
The 1:1:1 question. Classical texts specify equal parts and several traditions use unequal ones. Since the three fruits differ in tannin class and in how strongly they act on the bowel, the ratio is a dose decision, and almost no product states it. If the ratio is not on the label, the formula is unspecified.
The one certificate that actually matters here. A survey of Ayurvedic medicines bought over the internet from both US and Indian manufacturers found lead, mercury and arsenic in the products Saper 2008. For this category, a heavy-metals certificate of analysis by ICP-MS on the specific finished lot is not a nice-to-have; it is the difference between a botanical and an exposure. Ask for the lot number on the certificate to match the lot number on the bottle.
What would have to be true, and how you would know it was not
1. The bowel response is dose-titratable within days, which tells you what it is. Predict that a change appears within 2 to 4 doses at an effective amount and disappears within 2 or 3 days of stopping. That timescale belongs to a direct luminal action, not to a tonic that builds. If a person has taken it nightly for 6 weeks and reports the effect is still deepening, the mechanism they are describing is not the one this page can support.
2. The safety prediction, and it is the one worth actually paying for. If you take an Ayurvedic multi-herb daily, predict a heavy-metals panel that is unchanged from your own pre-supplement baseline at 6 and 12 months. Blood lead is the specific number Saper 2008. A rise is not ambiguous and it is not diet.
3. The prediction that cuts against the product. Predict hs-crp and lipid-panel do not move at 12 weeks on 500 mg to 1 g. The antioxidant story is an in vitro story, the human randomized record is a microbiome trend in nine people at four times that dose Peterson 2020, and no human trial has reported a clinically meaningful change in either marker at label dose. If they do move, something else in the routine changed.
4. A prediction from the urolithin chemistry that nobody has tested. If the systemic half of this formula depends on converting ellagitannins to urolithins, then responders should be the people who also respond to pomegranate and to walnuts, and non-producers should get only the local astringent and bowel effects. That predicts a sharply bimodal response with no middle, and it predicts that anyone who has taken pomegranate extract without effect will find this one does nothing systemic either. Cheap to test, never tested.
5. Iron, in the direction people do not expect. If the tannin content is real, predict ferritin drifts DOWN rather than up in someone taking a gram of hydrolyzable tannin with an evening meal for 6 months, particularly a menstruating woman on a plant-based diet. Retest ferritin at 6 months. This is a prediction of harm from the mechanism the product is sold on.
What nobody has tested yet
Nobody has run it at the dose people take. The randomized microbiome pilot used 2 g Peterson 2020 and the market sells 500 mg. Whether the label dose does anything at all is an open question, and the study that would answer it is the study that was already run, repeated one notch lower.
Nobody has done the factorial. The central claim of this formula is that three fruits together do something none does alone. That is a four-arm trial — each fruit, and the combination — with one endpoint, and in two thousand years of continuous use it has not been done. Until it is, the synergy claim is a tradition rather than a finding.
Nobody has stratified anyone by urolithin metabotype. The conversion pathway is well described for other ellagitannin sources and has never been measured in a triphala trial. One urine sample at 24 hours would sort a cohort into producers and non-producers, and it would probably explain most of the disagreement in the literature.
And nobody has separated the tannins from the rest. A tannin-depleted preparation against the whole fruit powder, same milligrams, same people, bowel movements counted, would settle whether the astringent chemistry is the active principle or a passenger. It has never been made.
Triphala — its own safety story, not its category's
Heavy metals are this product's own risk, not a generic botanical caution. A JAMA survey of Ayurvedic medicines bought online from manufacturers in both countries found lead, mercury and arsenic in the products Saper 2008. Some Ayurvedic preparations contain metals by design; a three-fruit formula is not one of them, which means any metal found in a triphala lot arrived by contamination and is therefore both avoidable and lot-specific. That is exactly the situation a certificate of analysis solves and a brand name does not.
The interaction almost nobody states: this formula binds iron. Hydrolyzable tannins are among the strongest known inhibitors of non-heme iron absorption, and this is a concentrated source of them taken at night, often with or near food. Anyone taking an iron supplement, anyone with a low ferritin, and anyone menstruating on a low-meat diet should be putting several hours between the two. The same chemistry that makes it astringent is what does this, so it is not an impurity problem that a better brand fixes.
Loose stools are the dose signal and also the failure mode. Reduce rather than persist. Sustained diarrhea from a nightly herbal is a route to potassium loss and dehydration in an older adult, and it is the mechanism by which a “gentle” product causes a real problem.
Glucose and platelets. It lowers blood glucose, so it stacks with diabetes medication rather than running parallel to it, and mild antiplatelet activity means it belongs in the pre-surgery stop list. Avoid in pregnancy and during any diarrheal illness, where adding a bowel-active preparation to fluid loss is the wrong direction.
Timing against everything else. A tannin-rich astringent reduces absorption of more than iron. Thyroid hormone, minerals and any narrow-margin drug should be two hours clear of it — and because this one is taken at night, that clash is with the bedtime medications people forget to count.
Sources read for this page
- Peterson CT, Denniston K, Chopra D. Therapeutic Uses of Triphala in Ayurvedic Medicine. Journal of Alternative and Complementary Medicine 2017 · PMID 28696777
- Tarasiuk A, Mosinska P, Fichna J. Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders. Chinese Medicine 2018 · PMID 30034512
- Peterson CT, Pourang A, Dhaliwal S, et al. Modulatory Effects of Triphala and Manjistha Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study. Journal of Alternative and Complementary Medicine 2020 · PMID 32955913
- Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA 2008 · PMID 18728265
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Regularity without urgency. The traditional positioning is a tonic rather than a purge, so the target is a bowel that moves on its own schedule — loose stool is not the win, it is the signal to take less.
- How long before it means anything: Two to four weeks taken at night. A gentle regulator behaves gradually; an overnight result is a stimulant effect and means the dose is above what you need.
- What will fool you: The dose of any single fruit in a three-fruit formula is usually unstated, so triphala is not a standard exposure and two brands are not the same experiment. The evidence base is also small and largely regional, which is worth knowing before you attribute a good month to it.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Triphala — safety & side effects
- Loose stools and cramping — it has mild laxative activity, which is the point.
- Lowers blood glucose; additive with diabetes medication. Mild antiplatelet activity.
- May reduce absorption of medication — separate by 2 hours. Avoid in pregnancy and in diarrheal illness. Ayurvedic products have a documented heavy-metal contamination problem; buy tested.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Triphala in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Triphala
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | Anemia is the commonest sign of a gut absorbing badly |
| Ferritin | Iron is the first thing malabsorption takes |
| Vitamin B12 | The second thing, and the one with permanent consequences |
| hs-CRP (High-Sensitivity C-Reactive Protein) | Separates inflammatory bowel disease from IBS |
The Gut Health & Absorption panel covers these in one order — 11 markers, $208.80 with the discount applied.
Check results you already have → · All 103 markers A–Z
Triphala — frequently asked questions
What is Triphala?
A three-fruit Ayurvedic combination used as a gentle bowel regulator — traditionally positioned as a tonic rather than a laxative.
What is the suggested dose of Triphala?
500 mg – 1 g at night. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Triphala dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Triphala?
Coach Cam sources Triphala from vetted, top-rated brands on iHerb — use the buy link on this page.
Triphala inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Triphala is used for
Triphala appears under 2 goals in the goal router.
Related Gut & Digestion supplements
Where this goes next
Triphala is the motility & ibs arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.